In the field of medicine, orphan drugs have stood out as silent heroes, bringing hope to those facing rare and neglected diseases. The term “orphan drugs” was first coined in the 1980s in the United States. The designation is given to drugs intended for the treatment of rare diseases, defined as those affecting 1 in […]
Monthly Archives: November 2023
In this second issue of #DiscoveringOligonucleotides, from the OLIGOFASTX consortium we want to introduce you to RNA therapeutics. In the field of medicine, RNA therapies stand as pioneers, offering new approaches and promising advances in the treatment of diseases hitherto thought unattainable. RNA therapies operate at the most fundamental level of genetic information, using different […]
Science Week is a unique opportunity to get closer to the fascinating world of science. During this week there are various activities and events where you can learn first-hand about the latest advances and discoveries in different areas of science. Don’t miss the opportunity to take part in Science Week and broaden your knowledge! Science […]
At the intersection of technological innovation and healthcare, artificial intelligence (AI) is emerging as a transformative tool in the pharmaceutical industry. This pairing promises to accelerate the discovery of new medicines, optimise production processes and improve patient care. However, with the promise comes a number of challenges and ethical conflicts that must be carefully addressed […]
Therapeutic oligonucleotides have emerged as an exciting and promising class of drugs capable of offering treatments for genetic and/or rare diseases. These DNA or RNA fragments have revolutionised the field of modern medicine… In this blog, we will explore what therapeutic oligonucleotides are, how they work and their potential applications, with a special focus on […]